NCT02812771View on ClinicalTrials.gov

Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 4, 2016

Primary Completion Date

January 14, 2019

Study Completion Date

January 14, 2019

Conditions

Onychomycosis

Interventions

DRUG

Efinaconazole

Solution

Trial Locations (10)

11375

Valeant Site 02, Forest Hills

19107

Valeant Site 06, Philadelphia

21214

Valeant Site 08, Baltimore

33143

Valeant SIte 05, South Miami

35201

Valeant Site 01, Birmingham

70130

Valeant Site 09, New Orleans

78501

Valeant Site 07, McAllen

92708

Valeant Site 04, Fountain Valley

95403

Valeant Site 03, Santa Rosa

Unknown

Valeant Site 10, Santo Domingo

All Listed Sponsors

lead

Bausch Health Americas, Inc.

INDUSTRY

NCT02812771 - Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis | Biotech Hunter | Biotech Hunter